SCHEMBL14446471

SCHEMBL14446471

CCOP(C)(=O)C(F)(F)C(=O)c1cnc(C)c(O)c1CO

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ HPGD P15428 2/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ LMNA P02545 2/20 0.35
▸ ESR1 P03372 1/20 0.32
▸ PTGS1 P23219 1/20 0.32
▸ ACP1 P24666 1/20 0.32
▸ PDE4A P27815 1/20 0.32
▸ P2RX1 P51575 1/20 0.32
▸ P2RX2 Q9UBL9 1/20 0.32
▸ PNPO Q9NVS9 1/20 0.32
▸ PDXK O00764 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ AOX1 Q06278 1/20 0.32
▸ TRIM24 O15164 1/20 0.31
▸ TRIM33 Q9UPN9 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4577413 0.89 KDM4E (0.40) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL5427118 0.83 KDM4E (0.45) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL4576064 0.71 KDM4E (0.40) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL4405851 0.69 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL11450921 0.69 KDM4E (0.58) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL3443069 0.68 KDM4E (0.56) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL11016595 0.65 KDM4E (0.51) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL4576069 0.64 KDM4E (0.39) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL13988518 0.64 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL5420558 0.64 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070167411-A1 Compositions for treating angina MEDICURE INTERNATIONAL INC. (BB) 2007-07-19 — — US disclosed
US-20070032456-A1 Modulation of cell death MEDICURE INC. (CA) 2007-02-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070167411-A1 Compositions for treating angina PNPO, PYGM, PLPBP KDM4E 2123/4885ALDH1A1 1367/4885HPGD 153/4885
US-20070032456-A1 Modulation of cell death CASP6, CASP3, CASP5 KDM4E 1592/4885ALDH1A1 3492/4885HPGD 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback